GleamWall
中文EN

ICCC IMMUCELL CORP /DE/

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 811641 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.6%
TTM net income YoY-19.1%
TTM EPS YoY-32.1%
Revenue 3-yr CAGR26.8%
Net income 3-yr CAGR—

Margins

Gross margin40.8%
Operating margin14.5%
Net margin5.7%
FCF margin16.3%
EBITDA margin21.0%

Returns

ROE6.0%
ROA4.2%
ROIC (approx.)13.8%
Asset turnover0.73x

Leverage & solvency

Liabilities / assets31.7%
Debt / equity0.24x
Current ratio4.61x
Interest coverage12.19x

Cash quality & payout

Operating cash flow / net income4.17x
Accruals ratio-13.2%
Payout ratio—
Capex / revenue7.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$27.64M$26.49M
Cost of revenue$16.20M$18.55M
Gross profit$11.45M$7.94M
R&D expense$3.04M$3.90M
SG&A expense$3.20M$2.22M
Operating income$1.65M-$1.64M
Interest expense$493,384$568,725
Pretax income-$1.03M-$2.15M
Income tax$11,570$10,056
Net income-$1.04M-$2.16M
EBITDA$4.43M$1.09M
EPS (basic)-0.12-0.26
EPS (diluted)-0.12-0.26
Weighted avg. shares (diluted)9.03M8.17M
Balance sheet
Cash & equivalents$3.81M$3.76M
Receivables$3.42M$3.77M
Inventory$9.27M$7.11M
Current assets$16.94M$15.04M
PP&E, net$21.07M$25.35M
Goodwill$95,557$95,557
Intangibles$0$19,104
Total assets$42.53M$45.10M
Current liabilities$3.98M$4.41M
Short-term debt$1.61M$1.50M
Long-term debt$7.49M$9.04M
Total debt$9.10M$10.54M
Total liabilities$15.48M$17.58M
Shareholders' equity$27.06M$27.52M
Net debt$5.29M$6.78M
Shares outstanding9.05M8.98M
Cash flow statement
Operating cash flow$2.48M$357,903
Capital expenditure$1.25M$465,725
Free cash flow$1.22M-$107,822
Investing cash flow-$1.21M-$461,225
Financing cash flow-$1.21M$2.88M
Depreciation & amortization$2.78M$2.73M
Stock-based compensation$295,871$325,551

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.